Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry - Beyer-Westendorf, J; Gelbricht, V; Förster, K (Br J Clin Pharmacol, 2014)
, et al.